![Banseog [ biohealth ]](/assets/brand/banseog-biohealth-on-dark.svg?v=20261015){kind=small}
A drugmaker founded in 1971 that produces tablets, capsules and transdermal patches and plasters (TDDS), and runs contract manufacturing (CDMO/ODM), export and health and beauty businesses.
Draws on more than 20 years of transdermal manufacturing to make tulobuterol, rivastigmine and nicotine patches and flurbiprofen, diclofenac sodium and ketoprofen plasters, supplying Korean drugmakers under contract and exporting abroad.
Combination tablet of donepezil and memantine for moderate to severe Alzheimer's dementia, launched in July 2026.
Multivitamin tablet combining high-dose B vitamins with minerals, antioxidants, choline bitartrate and UDCA (16 nutrients in all), launched in July 2026.
Chungju plant on a 29,861 m2 site with KGMP lines for tablets, hard capsules, patches, plasters and ointments; annual capacity includes 1.08 billion tablets and 90 million plasters. Soft capsules and injectables are outsourced.
Launched a new over-the-counter cold medicine in soft capsule form.
Launched a 10/20 mg donepezil and memantine combination tablet for Alzheimer's dementia, combining both drugs in one tablet.
Launched a multivitamin tablet combining benfotiamine and fursultiamine in July 2026.
Official role guide
Observed 2026-10-26
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.